Clarity Pharmaceuticals Health Care
Biotech Cancer Healthcare North America Pharmaceuticals

$0.700 0.005 (0.72%)

High $0.72	Low $0.70	Trades 33	Turnover $39,512	Volume 56,305
30 June 2023 at 4:10pm

Market Cap (24-Jul) $876,740,800 (700th)	Close (30-Jun) $0.70 0 (0%)	Volume (30-Jun) 56,305	Shortsold (20-Jul) 30,565,971 (8.19%) (29th)
52w High $5.87	52w Low $1.80	P/E -	EPS -0.28

Short Interest

ASIC data, 20 Jul 2026

% Shorted

8.19% 0.07

vs 8.12% prior report

Most Shorted Rank

29th

of 709 shorted ASX stocks

Peak Short

10.24%

Jul 2025

Days to Cover

10.7

at 50d avg vol

View full short position history →

	Subject
	CU6 CU6 Article: Clarity Pharmaceuticals readies mega capital raising
	1 (current) 2 3
	CU6 CU6 Article: Three ASX companies jockeying to be the next biotech winners
	CU6 CU6 Article: Clarity Pharmaceuticals preps $110m raise; Bells, Wilsons mandated
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Clarity Establishes US Center of Excellence for Research
	CU6 CU6 Ann: Northstar Achieves Key Production Milestones
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: COMBAT theranostic prostate cancer trial commences in the US
	CU6 CU6 Ann: Clarity expands supply of Cu-64 for Phase III trials
	CU6 CU6 Ann: Presentation at Jefferies Healthcare Conference
	CU6 CU6 Ann: Recruitment complete for Phase II prostate cancer trial
	CU6 CU6 Ann: Clarity to present at ASCO and SNMMI 2023 Annual Meetings
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Theranostic prostate cancer trial advances to cohort 2
	CU6 CU6 Ann: Final Director's Interest Notice - O'Bryan Tear
	CU6 CU6 Ann: Initial Director's Interest Notice
	CU6 CU6 Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CU6 CU6 Ann: Clarity Receives $6.7 million R&D Tax Incentive Refund
	CU6 CU6 Ann: Notification of cessation of securities - CU6
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Clarity update on NorthStar copper-67 production
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Clarity Corporate Presentation
	CU6 CU6 Ann: Clarity confirms no supply interruptions
	CU6 CU6 Ann: World leading expert in copper-67 joins Clarity SAB
	CU6 CU6 Ann: Half Yearly Report and Accounts
	CU6 CU6 Ann: Appendix 4D
	CU6 CU6 Ann: Change of Director's Interest Notice - Biggin
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: 50% recruitment milestone for NET diagnostic Phase II trial
	CU6 CU6 Ann: PROPELLER Trial Results
	CU6 CU6 Ann: Ceasing to be a substantial holder
	CU6 CU6 Article: GenesisCare drops Clarity Pharma stake, Wilsons on trade
	CU6 CU6 Ann: Diagnostic prostate cancer trial reaches recruitment target
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Changes to Clarity Board of Directors
	CU6 CU6 Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Positive topline results from SAR-bisPSMA diagnostic trial
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Change of Director's Interest Notices - Taylor and Biggin
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Clarity Corporate Presentation & Webinar
	CU6 CU6 Ann: Clarity Corporate Presentation & Webinar

End of Day Prices

Date	Close	Volume	Change
24-Jul	$2.35	2,294,721	-0.21 (8.20%)
23-Jul	$2.56	2,911,546	+0.22 (9.40%)
22-Jul	$2.34	1,802,014	+0.11 (4.93%)
21-Jul	$2.23	2,368,760	-0.09 (3.88%)
20-Jul	$2.32	1,158,733	0.00 (0.00%)
17-Jul	$2.32	2,561,920	-1.21 (34.28%)
18-Sep	$3.53	1,598,701	+0.29 (8.95%)
12-Sep	$3.24	1,527,582	+0.11 (3.51%)
11-Sep	$3.13	1,661,390	-0.04 (1.26%)
05-Sep	$3.17	1,197,820	+0.04 (1.28%)
04-Sep	$3.13	1,687,219	+0.03 (0.97%)
03-Sep	$3.10	2,046,917	+0.12 (4.03%)
29-Aug	$2.98	4,850,945	-0.20 (6.29%)
28-Aug	$3.18	2,981,913	-0.21 (6.19%)
22-Aug	$3.39	2,593,743	-0.15 (4.24%)
7 up, 7 down, and 1 flat days

Clarity Pharmaceuticals Health Care
Biotech Cancer Healthcare North America Pharmaceuticals

Short Interest

Followers

Prices

Announcements

End of Day Prices

CU6 Clarity Pharmaceuticals Health Care Biotech Cancer Healthcare North America Pharmaceuticals

Short Interest

Followers

Prices

Announcements

End of Day Prices

Clarity Pharmaceuticals Health Care
Biotech Cancer Healthcare North America Pharmaceuticals